IP Library Granted Patent US 9,759,728
Granted Patent B2
US 9,759,728 · App. 14/913,856 · Granted Sep 12, 2017

Methods for determining human sperm quality

Inventors: Nicolas Sergeant (Lille, FR); Valerie Mitchell (Lille, FR); Fanny Jumeau (Rouen, FR); Julien Sigala (Lille, FR)
Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Droit et de la Sante de Lille 2; Centre Hospitalier Regional Universitaire de Lille
G01N33/689G01N2333/91215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,759,728
App. No.
14/913,856
Granted
Sep 12, 2017
Kind
B2
Abstract

The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and kits for determining the human sperm quality.

Claims (38)

1. A method for assessing sperm fertility rate in an infertile or hypofertile subject or a subject with difficulty to conceive for more than one year, comprising the steps of:

i) liquefying a semen sample obtained from said subject at 37° C. for 30 minutes,

ii) isolating spermatozoa from said semen sample through a single-step density gradient centrifugation,

iii) washing said isolated spermatozoa with tris-buffered saline,

iv) homogenizing said isolated spermatozoa with a lysis buffer to obtain a spermatozoa protein lysate,

v) measuring the expression level of one or both of a kinase anchoring protein 4 (AKAP4) and Hexokinase 1 in said protein lysate, and

vi) comparing said measured expression level with a reference value, wherein detecting a differential in the expression of the one or both of AKAP4 and Hexokinase 1 between the sample and the reference value is indicative of sperm fertility rate.

2. The method according to claim 1 wherein said subject is classified as a normozoospermic subject.

3. The method according to claim 1 , wherein said tris-buffered saline comprises 0.1 mM of HCl, 100 mM of NaCl, and has a pH equal to 7.6.

4. The method according to claim 1 , wherein step v) is performed by

analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining,

providing a numerical analysis of said blue stained gel,

selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa,

representing each band by a densitometric curve and calculating the area under the densitometric curve, and

calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities.

5. The method according to claim 4 wherein a ratio between 1 to 2 is indicative of good sperm quality, and a ratio above 2 is indicative of bad sperm quality.

6. The method according to claim 3 , wherein step v) is performed by

analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining,

providing a numerical analysis of said blue stained gel,

selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa,

representing each band by a densitometric curve and calculating the area under the densitometric curve, and

calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities.

7. A method enabling an infertile or hypofertile subject or a subject with difficulty to conceive for more than one year to determine the most successful assisted-reproductive technology comprising the steps of:

i) liquefying a semen sample obtained from said subject at 37° C. for 30 minutes,

ii) isolating spermatozoa from said semen sample through a single-step density gradient centrifugation,

iii) washing said isolated spermatozoa with tris-buffered saline,

iv) homogenizing said isolated spermatozoa with a lysis buffer to obtain a spermatozoa protein lysate,

v) measuring the expression level of one or both of AKAP4 and Hexokinase 1 in said protein lysate, and

vi) comparing said measured expression level with a reference value, wherein detecting a differential in the expression of the one or both of AKAP4 and Hexokinase 1 between the sample and the reference value is indicative of a given assisted reproductive technology.

8. The method according to claim 7 , wherein step v) is performed by

analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining,

providing a numerical analysis of said blue stained gel,

selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa,

representing each band by a densitometric curve and calculating the area under the densitometric curve, and

calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities,

wherein when said ratio is above 2 choosing intrauterine insemination (IUI) as an assisted-reproductive technology.

9. The method according to claim 7 , wherein said tris-buffered saline comprises 0.1 mM of HCl, 100 mM of NaCl and has a pH equal to 7.6.

10. The method according to claim 7 , wherein said subject is classified as a normozoospermic subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2016
From: SERGEANT, NICOLAS; MITCHELL, VALERIE; JUMEAU, FANNY; SIGALA, JULIEN
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2; CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE
Reel/Frame 037889/0462 →
Priority Claims (1)
EP 13306212 · Sep 5, 2013 · regional
Continuity (1)
Related Publication 20160356785A1 · Dec 8, 2016